Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.
about
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsMicrovesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients.Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.
P2860
Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@en
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@nl
type
label
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@en
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@nl
prefLabel
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@en
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@nl
P2093
P2860
P1476
Distinguishing pseudoprogressi ...... otential value of 18F-FDG PET.
@en
P2093
Charles M Laymon
Frank S Lieberman
James M Mountz
Matthew J Oborski
P2860
P304
P356
10.1097/RLU.0B013E318286C148
P577
2013-05-01T00:00:00Z